Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising outcomes. However, the price of this innovative drug and its availability have become key concerns for patients and healthcare practitioners. While tirzepatide has been approved by regulatory agencies, its high-priced nature presents a significant challenge